|
Fresenius Kabi Oncology Limited was incorporated in the year 2003. The company is engaged in cancer research and anti-cancer products. The Company undertakes generics drug development, API development, finished product development and generics products registrations worldwide. Its primary business segments include Formulation and Bulk Drug. The Company’s oncology portfolio includes Anastrozole, Docetaxel Trihydrate, Oxaliplatin, Bicalutamide, Docetaxel Anhydrous, Paclitaxel, Busulfan, Gemcitabine HCI, Temsirolimus, Carboplatin, Irinotecan HCI, Topotecan HCI, Decitabine, Letrozole and Vinorelbine. The Company manufactures and distributes dosage forms through its two plants in Baddi, Himachal Pradesh and Nalagarh, Himachal Pradesh. Its API production plant at Kalyani, West Bengal develops, validates and manufactures key APIs. Its generic products include Taxane Analogues, Alkylating Agents, Anti-Metabolites and Cytostatic Antibiotics.
The company has its shares listed on BSE and NSE.
Below you will find details about Fresenius Kabi Oncology Company Profile, Share Price, News, Address, Management, Registrar and Contact Details.
|
|
M C S Ltd. Sri Venkatesh Bhawan
No. W-40,
Okhala Industrial Area Phase -II
Tel: 41406149, 41406150, 41406151, 41406152
Fax: 41709881
|
